The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetro Matad Regulatory News (MATD)

Share Price Information for Petro Matad (MATD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.05
Bid: 3.00
Ask: 3.10
Change: 0.10 (3.39%)
Spread: 0.10 (3.333%)
Open: 2.95
High: 3.30
Low: 2.95
Prev. Close: 2.95
MATD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Retail Offer by PrimaryBid

14 Jul 2021 16:36

RNS Number : 2706F
Petro Matad Limited
14 July 2021
 

 

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF PETRO MATAD LIMITED.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021)

 

14 July 2021

 

Petro Matad Limited

("Petro Matad" or the "Company")

Retail Offer by PrimaryBid

 

Petro Matad (LON: MATD), the AIM quoted Mongolian oil company, is pleased to announce, a conditional offer for subscription via PrimaryBid (the "Retail Offer") of new ordinary shares of 0.01 USD each in the Company ("New Ordinary Shares") at an issue price of 3.5 pence per New Ordinary Share (the "Issue Price"), being a discount of 36 per cent to the closing mid-price on 13 July 2021. The Company is also conducting a placing of new Ordinary Shares at the Issue Price by way of an accelerated bookbuild process (the "Placing") as announced today. In addition, certain of the Company's shareholders and directors of the Company intend to subscribe for new ordinary shares in the capital of the Company alongside the Placing (the "Subscription"), at the Issue Price.

The Company also intends to raise gross proceeds of up to approximately USD$ 2 million through the issue of approximately 43 million new Ordinary Shares (the "Open Offer Shares") pursuant to an open offer (the "Open Offer") to allow shareholders of the Company, including those who are not participating in the Placing, to subscribe for new Ordinary Shares at the Issue Price.

The Retail Offer and the Placing, together with the Subscription and Open Offer ("the Fundraise"), are conditional upon the New Ordinary Shares to be issued pursuant to the Retail Offer and the Placing being admitted to trading on AIM ("Admission"). Admission is expected to take place at 8.00 a.m. on 22nd July 2021, or such later time and/or date as the Joint Bookrunners and the Company agree being in any event no later than 8.00 a.m. on 21 August 2021. The Retail Offer will not be completed without the Placing also being completed.

The Company will use the net proceeds of the Fundraise to:

 • Fund the completion of the Heron 1 and install well site production equipment;

• Drill and complete for production (if successful) H2 and H3 wells;

• Start production in mid-2022 with processing and export via adjacent Petro China operated facilities;

• Recruit a farm in partner, if acceptable terms can be agreed, in order to accelerate Heron full field development and to join in exploration efforts;

• Fund a portion of the Company's Production Sharing Contract expenses;

• Fund a portion of G&A and other corporate expenses.

Retail Offer

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the Retail Offer by applying exclusively through the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

The Retail Offer, via the PrimaryBid mobile app, will be open to individual and institutional investors following the release of this announcement. The Retail Offer is expected to close at 8 p.m. tonight. The Retail Offer may close early if it is oversubscribed.

The Company reserves the right to scale back any order at its discretion. The Company and PrimaryBid reserve the right to reject any application for subscription under the Retail Offer without giving any reason for such rejection.

No commission is charged to investors on applications to participate in the Retail Offer made through PrimaryBid. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

For further information on PrimaryBid or the procedure for applications under the Retail Offer, visit www.PrimaryBid.com or email PrimaryBid at enquiries@primarybid.com. 

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's existing Ordinary Shares.

It is a term of the Retail Offer and the Open Offer that the total value of the Retail Offer and the Open Offer available for subscription at the Placing Price does not exceed €8 million in order to ensure that the Company is not required to publish (and the Company has not published) a prospectus in connection with the Retail Offer as it falls within the exemption set out in section 86(1)(e) and 86(4) of FSMA.

 

Petro Matad Limited

Mike Buck, Chief Executive Officer 

 

 

+976 7014 1099

PrimaryBid Limited

William Keith / James Deal

 

enquiries@primarybid.com

Shore Capital Stockbrokers Limited, Nominated Advisor, Broker, Joint Bookrunner

Toby Gibbs / John More (Corporate Advisory)

Jerry Keen (Corporate Broking)

 

 

+44 207 408 4050

Arden Partners plc (Joint Bookrunner)

Paul Shackleton / Akhil Shah / Oscair McGrath (Corporate Finance)

Tim Dainton (Equity Sales)

 

 

+44 207 614 5900

Details of the Retail Offer

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the Retail Offer. The Company is therefore making the Retail Offer available exclusively through the PrimaryBid mobile app.

The Retail Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of a prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The Retail Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so.

There is a minimum subscription of £250 per investor under the terms of the Retail Offer which is open to existing shareholders and other investors subscribing via the PrimaryBid mobile app.

For further details please refer to the PrimaryBid website at www.PrimaryBid.com. The terms and conditions on which the Retail Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on www.PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt. 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUSRVRAWUBAAR
Date   Source Headline
25th Apr 20247:00 amRNSOperational Update
17th Apr 20247:00 amRNSNotice of AGM Logistics
3rd Apr 20247:00 amRNSNotice of AGM
1st Mar 202412:14 pmRNSOperational Update
19th Dec 20237:00 amRNSOperational Update
28th Sep 20237:00 amRNSInterim results and Operational Update
10th Jul 20237:00 amRNSOperational Update: Velociraptor-1 well results
6th Jul 20237:00 amRNSOperational Update: Block XX Land Permit
20th Jun 20237:00 amRNSFinal results for year ended 31 December 2022
14th Jun 20237:00 amRNSOperational Update - Spud of Velociraptor-1
31st May 20237:00 amRNSAward of New Options
22nd May 20237:00 amRNSOperational Update
3rd Apr 20237:00 amRNSOperational Update
3rd Mar 202311:05 amRNSSecond Price Monitoring Extn
3rd Mar 202311:00 amRNSPrice Monitoring Extension
15th Feb 202312:25 pmRNSResult of AGM
14th Feb 20237:00 amRNSOperational Update
9th Feb 20237:00 amRNSNotice of AGM Logistics
8th Feb 20237:00 amRNSResult of Retail Offer
3rd Feb 20237:00 amRNSResults of Capital Raise
2nd Feb 20235:02 pmRNSRetail Offer
2nd Feb 20234:41 pmRNSProposed fundraise for a minimum of US$4.0 million
20th Jan 20237:00 amRNSNotice of AGM
19th Jan 20237:00 amRNSChange of Adviser
9th Jan 20239:00 amRNSPrice Monitoring Extension
4th Jan 20232:05 pmRNSSecond Price Monitoring Extn
4th Jan 20232:00 pmRNSPrice Monitoring Extension
3rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
3rd Jan 20232:00 pmRNSPrice Monitoring Extension
30th Dec 202211:05 amRNSSecond Price Monitoring Extn
30th Dec 202211:00 amRNSPrice Monitoring Extension
8th Dec 20222:05 pmRNSSecond Price Monitoring Extn
8th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSOperational Update
22nd Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results & Operational Update
27th Jun 20227:00 amRNSFinal Results for Year Ended 31 December 2021
5th May 20227:00 amRNSOperational Update
21st Mar 20224:36 pmRNSPrice Monitoring Extension
4th Mar 202211:32 amRNSInvestor Conference
3rd Mar 20221:08 pmRNSResult of AGM
2nd Mar 20227:00 amRNSNotice of AGM Logistics
25th Feb 20227:00 amRNSOperational Update
7th Feb 20222:30 pmRNSNotice of AGM
24th Jan 20224:42 pmRNSSecond Price Monitoring Extn
24th Jan 20224:37 pmRNSPrice Monitoring Extension
19th Jan 20227:18 amRNSProgressive publishes new research
18th Jan 202211:06 amRNSSecond Price Monitoring Extn
18th Jan 202211:00 amRNSPrice Monitoring Extension
15th Dec 20217:00 amRNSConditional Share Awards and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.